Related Experiment Video
Updated: Jun 15, 2025

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
80.6K
WHO target product profile for TB detection at peripheral settings: 2024 update
Mikashmi Kohli1, Alexei Korobitsyn2, Nazir Ismail2
1FIND, Geneva, Switzerland.
PLOS Global Public Health
|June 11, 2025
Summary
The World Health Organization updated its tuberculosis (TB) diagnostic test criteria, incorporating new evidence and modeling. Lower accuracy for accessible point-of-care tests is acceptable for improved TB case detection.
Area of Science:
- Infectious Diseases
- Public Health
- Medical Diagnostics
Background:
- The World Health Organization (WHO) established Target Product Profiles (TPPs) for TB diagnostics in 2014.
- Evolving needs and innovative platforms necessitate updated criteria for TB diagnostic tests, including non-sputum specimens.
Purpose of the Study:
- To update the TPPs for tuberculosis diagnostic tests, focusing on point-of-care, near point-of-care, and low-complexity assays.
- To incorporate evidence-based modeling into the TPP development process for the first time.
Main Methods:
- Followed standard WHO TPP development protocols, including Delphi process and public consultations.
- Utilized evidence-based modeling to inform decisions on assay characteristics.
- Focused on assays using both sputum and non-sputum specimens for peripheral settings.
Main Results:
- Modeling suggests that reduced accuracy for point-of-care tests is acceptable.
- Achieving comparable or better case detection than the current standard of care is feasible with updated criteria.
- Key updates focus on technical and operational specifications for peripheral TB diagnostics.
Conclusions:
- The updated TPP provides guidance for developing effective TB diagnostic tests for peripheral settings.
- The use of modeling represents a novel approach to TPP development.
- The updated profiles aim to improve TB diagnosis accessibility and effectiveness globally.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
Pulmonary Tuberculosis III
316
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
316

